SciVision Biotech Inc (1786) — Working Capital to Net Assets Ratio
SciVision Biotech Inc (1786) has a Working Capital to Net Assets ratio of 62.0% as of March 2026. Working capital of NT$1.15 Billion (current assets of NT$1.53 Billion minus current liabilities of NT$373.20 Million) is measured against net assets of NT$1.86 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See SciVision Biotech Inc (1786) defensive interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
SciVision Biotech Inc Working Capital to Net Assets (2009–2025)
This chart shows how SciVision Biotech Inc's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2009 to 2025. As of March 2026, the ratio stands at 62.0%, reflecting working capital of NT$1.15 Billion against net assets of NT$1.86 Billion TWD. For the complete balance sheet picture, see how large is SciVision Biotech Inc's balance sheet.
Annual Working Capital to Net Assets for SciVision Biotech Inc (2009–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for SciVision Biotech Inc from 2009 to 2025, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check SciVision Biotech Inc (1786) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 63.3% | NT$1.25 Billion | NT$1.98 Billion | NT$1.43 Billion | NT$174.65 Million | ▲ +19.5 pp |
| 2024 | 43.7% | NT$829.35 Million | NT$1.90 Billion | NT$1.17 Billion | NT$337.07 Million | ▼ -9.1 pp |
| 2023 | 52.8% | NT$858.92 Million | NT$1.63 Billion | NT$1.00 Billion | NT$144.99 Million | ▲ +3.0 pp |
| 2022 | 49.8% | NT$752.95 Million | NT$1.51 Billion | NT$881.03 Million | NT$128.08 Million | ▲ +15.4 pp |
| 2021 | 34.5% | NT$499.60 Million | NT$1.45 Billion | NT$925.24 Million | NT$425.64 Million | ▲ +3.7 pp |
| 2020 | 30.8% | NT$431.84 Million | NT$1.40 Billion | NT$553.45 Million | NT$121.61 Million | ▲ +1.6 pp |
| 2019 | 29.1% | NT$396.55 Million | NT$1.36 Billion | NT$546.78 Million | NT$150.22 Million | ▲ +0.1 pp |
| 2018 | 29.0% | NT$312.83 Million | NT$1.08 Billion | NT$523.55 Million | NT$210.72 Million | ▼ 0.0 pp |
| 2017 | 29.0% | NT$265.57 Million | NT$914.45 Million | NT$449.66 Million | NT$184.09 Million | ▼ -15.5 pp |
| 2016 | 44.6% | NT$398.65 Million | NT$894.21 Million | NT$586.54 Million | NT$187.88 Million | ▼ -7.9 pp |
| 2015 | 52.5% | NT$497.96 Million | NT$948.60 Million | NT$565.62 Million | NT$67.67 Million | ▼ -22.6 pp |
| 2014 | 75.1% | NT$767.88 Million | NT$1.02 Billion | NT$810.61 Million | NT$42.73 Million | ▼ -11.5 pp |
| 2013 | 86.6% | NT$938.15 Million | NT$1.08 Billion | NT$963.40 Million | NT$25.25 Million | ▲ +12.5 pp |
| 2012 | 74.1% | NT$315.56 Million | NT$425.98 Million | NT$344.04 Million | NT$28.48 Million | ▲ +4.0 pp |
| 2011 | 70.0% | NT$254.71 Million | NT$363.70 Million | NT$267.64 Million | NT$12.94 Million | ▲ +74.1 pp |
| 2010 | -4.0% | NT$-4.52 Million | NT$111.73 Million | NT$68.22 Million | NT$72.74 Million | ▲ +46.2 pp |
| 2009 | -50.3% | NT$-42.26 Million | NT$84.09 Million | NT$24.49 Million | NT$66.75 Million | — |